Formication Menopause: Bug-Crawling Skin Sensations Explained
Formication is a menopause symptom causing crawling-insect sensations on skin due to falling estrogen. Learn causes and treatments that help, including HRT.
Does Topical Facial Estrogen Worsen Acne or Melasma?
A deep look at whether applying estrogen cream or serum to the face triggers acne breakouts or darkens melasma patches, with dosing context, skin biology, and practical guidance.
How Do I Lose Weight During Menopause? Weight Gain Tips
Evidence-based strategies for losing weight during menopause, including diet, exercise, hormone therapy, and GLP-1 options.
How Long Is Menopause?
A guide covering how long perimenopause, menopause, and postmenopause each last, what drives symptom duration, and when to consider hormone therapy.
How to Prevent Vaginal Dryness During Menopause
A guide to preventing and treating vaginal dryness during menopause, covering estrogen therapy, non-hormonal options, lifestyle changes, and when to seek care.
How to Restore Gut Microbiome Health During Menopause
The menopause transition reshapes your gut bacteria. Learn which evidence-based strategies, including diet, probiotics, and hormone therapy, can help restore gut microbiome health during menopause.
What Is Menopause? Symptoms, Stages, Diagnosis, and Treatment Explained
A complete clinical guide to menopause: what it is, the three stages, hallmark symptoms, how it's diagnosed, and evidence-based hormone therapy options prepared by the HealthRX.com Editorial Team.
Why Do My Joints Hurt? Menopause and Musculoskeletal Syndrome Explained
Joint pain during menopause is caused by estrogen loss that drives cartilage breakdown, synovial inflammation, and tendon stiffness. Learn the mechanisms, evidence-based treatments, and when hormone therapy actually helps.
Why I'm Passionate About Working at Alloy | Randi Friedman
Randi Friedman shares why she is passionate about working at Alloy Women's Health, how the telehealth platform is changing menopause and HRT care, and what clinicians and patients can expect from personalized hormone therapy.
Is HRT Safe for the Heart? 2026 Safety & Risks Guide
A breakdown of HRT and cardiovascular risk in 2026, covering the WHI reanalysis, timing hypothesis, oral vs. Transdermal estrogen, progestogen type, and who should avoid HRT.
Compounded Testosterone Cream for Women: Doses, Benefits, and What the Evidence Actually Shows
A guide to compounded testosterone cream for women, covering doses, clinical evidence, comparisons with vaginal estradiol and DHEA, flibanserin, and bremelanotide, and how to get a prescription.
Dyspareunia: Causes, Diagnosis, and Evidence-Based Treatment for Painful Sex in Women
A guide to dyspareunia covering genitourinary syndrome of menopause, vaginismus, HSDD, female orgasmic disorder, and treatments including topical estrogen, ospemifene, pelvic floor PT, and flibanserin.
Compounded Oxytocin and Women's Sexual Health: What the Evidence Actually Shows
A guide to compounded oxytocin, flibanserin, bremelanotide, vaginal estradiol, and vaginal DHEA for women's sexual health, including doses, evidence, and how to choose.
Surgical Menopause - Symptoms, Risks, and Treatment
Surgical menopause causes hormone levels to drop within 24 hours, often with more severe symptoms and earlier heart and bone risks than natural menopause.
Why Does Sex Hurt After Menopause? Causes, Treatments, and When to Ask for Help
Painful sex after menopause is caused by estrogen loss that thins vaginal tissue, reduces lubrication, and triggers GSM. Local estrogen, systemic HRT, ospemifene, testosterone, and lifestyle changes can restore comfort and desire. Learn which treatment fits your situation.
Reclast (Zoledronic Acid): What to Expect Week-by-Week in Your First Month
A clinician-level, week-by-week guide to the first 30 days after a Reclast (zoledronic acid) infusion, covering acute-phase reactions, bone-marker changes, fracture protection timelines, and what requires a call to your provider.
Ambien Cardiovascular Impact Long-Term: What the Evidence Actually Shows
Ambien lowers blood pressure mildly and briefly: a 10 mg dose drops systolic BP by 4-6 mmHg. Long-term nightly use can blunt the normal nocturnal dip.
Ambien Geriatric (65+) Monitoring: Zolpidem Safety, Dosing, and Deprescribing
A guide to zolpidem monitoring in adults 65 and older, covering Beers Criteria guidance, falls risk, renal and hepatic considerations, drug interactions, and evidence-based deprescribing strategies.
When Was Ambien Invented? 1992 FDA Approval History
Ambien (zolpidem) was synthesized by Synthelabo in France in the early 1980s and approved by the FDA in December 1992, with Ambien CR following in 2005.
Ambien (Zolpidem) Safety for Adults 50 to 64: What You Need to Know
A guide to zolpidem safety in adults aged 50 to 64, covering dose recommendations, fall risk, drug interactions, perimenopause overlap, and safer alternatives.
Topical Minoxidil for Adults 65 and Older: Caregiver Administration Guidance
Step-by-step caregiver guidance for applying topical minoxidil 5% to geriatric patients (65+), including dose, technique, safety checks, and when to call the prescriber.
Fosamax Dosing in Renal Impairment: What Prescribers Need to Know
A clinician-level guide to alendronate (Fosamax) dosing in renal impairment, covering mechanism, pharmacokinetics, the FIT trial, and evidence-based thresholds for dose adjustment or avoidance.
Praluent (Alirocumab): What to Expect Week by Week in Your First Month
A week-by-week guide to your first four weeks on Praluent (alirocumab): when LDL drops, what side effects appear, and what the ODYSSEY OUTCOMES trial data mean for your cardiovascular risk.
Alprostadil (Caverject/MUSE) Geriatric (65+) Dosing: A Clinical Guide
Evidence-based guide to alprostadil dosing in men aged 65 and older, covering intracavernosal injection and intraurethral suppository titration, renal adjustment, fall-risk management, and AUA guideline recommendations.
Alprostadil (Caverject/MUSE) Safety for Young Adults Ages 18 to 29
A guide to alprostadil safety for men aged 18, 29, covering injection technique, priapism risk, fertility considerations, dosing, and how to integrate on-demand therapy into an active young-adult lifestyle.
AndroGel Switching: Moving Between Testosterone Gel and Other TRT Formulations
A clinical guide to switching from AndroGel (testosterone gel 1% or 1.62%) to other testosterone formulations, or switching to AndroGel from injections, pellets, or patches. Includes dosing conversions, washout timing, and monitoring benchmarks.
Defy Medical Alternatives: Best Options for TRT, Peptides, and Longevity Care
A clinical comparison of Defy Medical alternatives across TRT, peptides, HRT, and longevity care. Includes cost data, prescribing scope, and use-case recommendations backed by primary sources.
Life Extension Prescription Process: What to Expect, What the Evidence Says
An independent clinical review of Life Extension's prescription intake process, supplement lineup, Rx offerings, costs, and how it compares to alternatives. Updated with cited trial data and physician commentary.
GIP/GLP-1 Dual Agonists Drug-Drug Interaction Table: Complete Prescriber Reference
A comprehensive drug-drug interaction table and prescribing guide for GIP/GLP-1 dual agonists (tirzepatide class), written at MD/PharmD level with primary-source citations.
Mounjaro vs Rybelsus: Cost and Access Head-to-Head
A clinical comparison of Mounjaro (tirzepatide) and Rybelsus (oral semaglutide) covering efficacy, cost, insurance access, dosing, and who each drug suits best.
Sermorelin vs CJC-1295: Head-to-Head Efficacy, Dosing, and Clinical Use
A detailed comparison of sermorelin acetate and CJC-1295 modified GRF covering mechanism, clinical evidence, dosing protocols, side effects, and how to choose between them.
PCOS Open Controversies: What Experts Still Disagree About
A look at the unresolved diagnostic, metabolic, and treatment controversies in polycystic ovary syndrome, framed around what a patient or clinician actually needs to decide.
Trulicity Mental Health and Mood Impact: What the Evidence Actually Shows
A clinician-level review of how dulaglutide (Trulicity) affects mental health and mood, covering GLP-1 receptor signaling in the brain, trial data, FDA safety communications, and practical monitoring guidance.
Trulicity (Dulaglutide) Dosing for Young Adults Ages 18 to 29
A guide to dulaglutide (Trulicity) dosing for young adults aged 18, 29 with type 2 diabetes, covering starting doses, titration schedules, injection technique, fertility considerations, and cardiovascular evidence from the REWIND trial.
Avodart Travel & Timezone-Shift Protocols: Dutasteride Dosing on the Road
Board-reviewed clinical guide to dutasteride (Avodart) travel protocols, timezone-shift dosing, storage rules, and what to do when doses are missed mid-journey.
Enclomiphene Citrate Plateau & Non-Response Troubleshooting
A structured approach to diagnosing why testosterone stalls on enclomiphene citrate: how to tell a lab-timing artifact from SHBG elevation, thyroid or prolactin interference, medication effects, or primary testicular failure, and when to reconsider the plan.
Lunesta Sexual Function Impact: What Eszopiclone Does to Libido, Arousal, and Performance
A clinical review of how eszopiclone (Lunesta) may affect libido, arousal, and hormonal signaling, what is established versus unproven, and a practical framework for sorting sedation from true sexual suppression.
Ezetimibe Dosing: When the Other Medicine Changes Your Schedule
Ezetimibe is usually taken as 10 mg once daily. Learn which medicines change its timing, what LDL trials show, and how heart-event evidence differs.
Finasteride Pharmacogenomics & Genetic Variability: A Complete Clinical Guide
How SRD5A1/SRD5A2 polymorphisms, CYP3A4 variants, and androgen-receptor genetics shape finasteride response, adverse-effect risk, and dosing decisions, with PubMed-cited evidence.
GHK-Cu Metabolism and Energy Expenditure: What the Evidence Actually Shows
A clinician-level review of GHK-Cu (copper tripeptide) and its documented effects on metabolism, mitochondrial function, and energy expenditure, with primary-literature citations and dosing context.
Does Anthem Cover Tirzepatide (Mounjaro)?
A detailed guide to Anthem's tirzepatide (Mounjaro) coverage policies, prior authorization requirements, formulary tiers, appeal strategies, and cost-saving options.
Why Does Calibrate Prescribe Saxenda® (Liraglutide)?
A explanation of why Calibrate uses liraglutide (Saxenda®) for metabolic health, including its mechanism, FDA approval history, dosing, side effects, and how it compares to newer GLP-1 agents.
Jatenzo and Atorvastatin Interaction: What Patients and Clinicians Need to Know
A guide to the Jatenzo (oral testosterone undecanoate) and atorvastatin drug interaction, covering CYP3A4 mechanisms, lipid monitoring, dose adjustment, and patient counseling.
Lisinopril and Gabapentin Interaction: What Patients and Clinicians Need to Know
How lisinopril (an ACE inhibitor) and gabapentin interact through kidney function rather than metabolism, what monitoring is warranted, and what remains unverified in commonly cited claims about this combination.
Losartan and Rosuvastatin Interaction: What Patients and Clinicians Need to Know
Losartan and rosuvastatin can generally be taken together, since they share no CYP interaction. The main concern is renal monitoring in kidney disease.
Prometrium and Alcohol: What the Drug Label and Clinical Data Actually Say
A full clinical review of the Prometrium, alcohol interaction profile, including CNS depression risk, pharmacokinetic overlap, and practical dosing guidance from the FDA label and primary literature.
Sildenafil and PPIs (Omeprazole, Pantoprazole): What the Drug Interaction Evidence Actually Shows
Can you take sildenafil with omeprazole or pantoprazole? A guide covering the CYP enzyme mechanism, clinical significance, dosing, and monitoring for this drug interaction.
Tretinoin and Progesterone HRT Interaction: What Patients and Prescribers Need to Know
A guide covering the pharmacokinetic and pharmacodynamic interaction between tretinoin topical and progesterone HRT, including CYP pathways, monitoring, dosing, and patient counseling backed by primary literature.
Wegovy and Finasteride Interaction: What Patients and Clinicians Need to Know
A clinical evidence review of the pharmacokinetic and pharmacodynamic considerations between semaglutide 2.4 mg (Wegovy) and finasteride, including what is established, what is plausible but unproven, and what should be verified before assuming the combination is risk-free.
Ambien and Opioids (Oxycodone, Hydrocodone, Tramadol) Interaction: What You Need to Know
Zolpidem (Ambien) combined with opioids such as oxycodone, hydrocodone, or tramadol causes additive central nervous system and respiratory depression. This article separates what regulators and pharmacology establish from what remains unverified, and includes a verification checklist for clinicians and pharmacists.
Accutane (Isotretinoin) Adult (30 to 49) Dosing: Complete Clinical Guide
Complete guide to isotretinoin dosing for adults aged 30 to 49, covering starting doses, cumulative targets, dose adjustments, iPLEDGE requirements, and what to expect during a course of treatment.
FibroScan / VCTE: How Nutrition and Fasting Change Your Liver Stiffness Score
Board-reviewed guide to how food intake, fasting duration, alcohol, and diet quality affect FibroScan (VCTE) results, with normal ranges, optimal values, and clinical protocols for MASLD staging.
Free T4: How to Interpret Your Result
A guide to understanding your Free T4 lab result, including normal ranges, what high and low values mean, and when treatment is needed.
Do You Need to Fast for a Urine Albumin/Creatinine Test?
No fasting required, but food, exercise and dehydration can skew uACR results 20-100%. Learn the best collection window and prep tips for accurate readings.
Liraglutide Dosing for Adults Ages 50 to 64: A Clinical Guide
How liraglutide is dosed and titrated in adults ages 50 to 64, including the FDA-approved titration schedule, cardiovascular and renal considerations, polypharmacy risks, and where trial evidence does and does not directly speak to this age group.
Mounjaro for Metabolic Syndrome: Evidence, Dosing, and What to Expect
A guide to using tirzepatide (Mounjaro) for metabolic syndrome, covering trial evidence, dosing schedules, and real-world outcomes.
Oral Estradiol for Mood: Evidence, Off-Label Use, and Risk-Benefit Tradeoffs
A guide to oral estradiol's off-label use for mood symptoms, covering the evidence base, GRADE ratings, FDA-approved indications, and key risks to weigh before prescribing.
Ozempic for NASH: Off-Label Use, Evidence, and Monitoring Requirements
A guide to using semaglutide (Ozempic 0.5 to 2.0 mg) off-label for NASH, covering the evidence base, GRADE ratings, required monitoring, and what FDA approval means for this indication.
Oral Micronized Progesterone Pharmacokinetics (ADME): Absorption, Distribution, Metabolism, and Excretion
A physician-level review of oral micronized progesterone (Prometrium) pharmacokinetics, covering absorption variability, peanut-oil matrix effects, hepatic metabolism, active neurosteroid metabolites, and clinical dosing implications backed by PubMed-cited evidence.
Oral Minoxidil: What to Expect Week by Week During Your First Month
A clinical week-by-week guide to oral minoxidil for hair loss. Learn what happens at weeks 1, 2, 3, and 4, what side effects to watch for, and what the evidence says about dose, response, and long-term results.